{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:46:56Z","timestamp":1786985216268,"version":"build-2736575974"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22307138"],"award-info":[{"award-number":["22307138"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018556","name":"Science and Technology Program of Suzhou","doi-asserted-by":"publisher","award":["KJXW2021030"],"award-info":[{"award-number":["KJXW2021030"]}],"id":[{"id":"10.13039\/501100018556","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002949","name":"Jiangsu Province People's Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFB3210300"],"award-info":[{"award-number":["2023YFB3210300"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.bioorg.2025.108596","type":"journal-article","created":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T11:00:23Z","timestamp":1747393223000},"page":"108596","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Development of an adenosine deaminase-resistant cordycepin prodrug activated by Pseudomonas carboxypeptidase G2"],"prefix":"10.1016","volume":"162","author":[{"given":"Zhang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houshi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gangyin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenfei","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4231","key":"10.1016\/j.bioorg.2025.108596_bb0005","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/166949a0","article-title":"Cordycepin, a metabolic product isolated from cultures of Cordyceps militaris (Linn.) link","volume":"166","author":"Cunningham","year":"1950","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bioorg.2025.108596_bb0010","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3892\/mmr.2024.13285","article-title":"Application and research progress of cordycepin in the treatment of tumours (review)","volume":"30","author":"He","year":"2024","journal-title":"Mol. Med. Rep."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108596_bb0015","first-page":"69","article-title":"Research Progress on Cordycepin synthesis and methods for enhancement of Cordycepin production in Cordyceps militaris","volume":"9","author":"Wang","year":"2022","journal-title":"Bioeng. (Basel)"},{"issue":"19","key":"10.1016\/j.bioorg.2025.108596_bb0020","doi-asserted-by":"crossref","first-page":"5886","DOI":"10.3390\/molecules26195886","article-title":"A systematic review of the biological effects of Cordycepin","volume":"26","author":"Radhi","year":"2021","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.bioorg.2025.108596_bb0025","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.nutres.2015.04.011","article-title":"Cordycepin from Cordyceps militaris prevents hyperglycemia in alloxan-induced diabetic mice","volume":"35","author":"Ma","year":"2015","journal-title":"Nutr. Res."},{"issue":"12","key":"10.1016\/j.bioorg.2025.108596_bb0030","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.3390\/molecules25122735","article-title":"Cordycepin for Health and Wellbeing: A Potent Bioactive Metabolite of an Entomopathogenic Cordyceps Medicinal Fungus and its Nutraceutical and Therapeutic Potential","volume":"25","author":"Ashraf","year":"2020","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"8","key":"10.1016\/j.bioorg.2025.108596_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1615\/IntJMedMushrooms.2022044442","article-title":"Cordycepin as a metabolite with pharmacological potential: a review","volume":"24","author":"Sharma","year":"2022","journal-title":"Int. J. Med. Mushrooms"},{"key":"10.1016\/j.bioorg.2025.108596_bb0040","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/0006-291X(64)90086-5","article-title":"Identification of cordycepin, a metabolite of Cordyceps militaris, as 3\u2032-deoxyadenosine","volume":"14","author":"Kaczka","year":"1964","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"23","key":"10.1016\/j.bioorg.2025.108596_bb0045","doi-asserted-by":"crossref","first-page":"14379","DOI":"10.1021\/acs.chemrev.6b00209","article-title":"Metabolism, biochemical actions, and chemical synthesis of anticancer nucleosides, nucleotides, and base analogs","volume":"116","author":"Shelton","year":"2016","journal-title":"Chem. Rev."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108596_bb0050","doi-asserted-by":"crossref","first-page":"12778","DOI":"10.3390\/ijms150712778","article-title":"Cordycepin down-regulates multiple drug resistant (MDR)\/HIF-1\u03b1 through regulating AMPK\/mTORC1 signaling in GBC-SD gallbladder cancer cells","volume":"15","author":"Wu","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.108596_bb0055","article-title":"Structural and pharmacological insights into cordycepin for neoplasms and metabolic disorders","volume":"15","author":"Zhang","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"8","key":"10.1016\/j.bioorg.2025.108596_bb0060","doi-asserted-by":"crossref","first-page":"4638","DOI":"10.1021\/jf100269g","article-title":"Pharmacokinetics of adenosine and cordycepin, a bioactive constituent of Cordyceps sinensis in rat","volume":"58","author":"Tsai","year":"2010","journal-title":"J. Agric. Food Chem."},{"issue":"13","key":"10.1016\/j.bioorg.2025.108596_bb0065","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.3390\/cancers14133122","article-title":"Cordycepin (3\u2019-deoxyadenosine) suppresses heat shock protein 90 function and targets tumor growth in an adenosine deaminase-dependent manner","volume":"14","author":"Lee","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.bioorg.2025.108596_bb0070","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.121","article-title":"Inhibition of adenosine deaminase (ADA)-mediated metabolism of cordycepin by natural substances","volume":"3","author":"Li","year":"2015","journal-title":"Pharmacol. Res. Perspect."},{"issue":"9","key":"10.1016\/j.bioorg.2025.108596_bb0075","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1002\/ptr.7921","article-title":"Cordycepin: a review of strategies to improve the bioavailability and efficacy","volume":"37","author":"Chen","year":"2023","journal-title":"Phytother. Res."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108596_bb0080","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3390\/molecules29020483","article-title":"Antitumor mechanism and therapeutic potential of Cordycepin derivatives","volume":"29","author":"Cui","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.108596_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2023.106466","article-title":"Design, synthesis, antibacterial\/antitumor activity and in vitro stability of novel cordycepin derivatives with unsaturated fatty acid chain","volume":"187","author":"Qu","year":"2023","journal-title":"Eur. J. Pharm. Sci."},{"issue":"23","key":"10.1016\/j.bioorg.2025.108596_bb0090","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1158\/1078-0432.CCR-21-1652","article-title":"The novel nucleoside analogue ProTide NUC-7738 overcomes Cancer resistance mechanisms in vitro and in a first-in-human phase I clinical trial","volume":"27","author":"Schwenzer","year":"2021","journal-title":"Clin. Cancer Res."},{"issue":"23","key":"10.1016\/j.bioorg.2025.108596_bb0095","doi-asserted-by":"crossref","first-page":"15789","DOI":"10.1021\/acs.jmedchem.2c01348","article-title":"Synthesis and characterization of NUC-7738, an Aryloxy Phosphoramidate of 3\u2019-deoxyadenosine, as a potential anticancer agent","volume":"65","author":"Serpi","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108596_bb0100","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.addr.2017.09.009","article-title":"Antibody directed enzyme prodrug therapy (ADEPT): trials and tribulations","volume":"118","author":"Sharma","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"32","key":"10.1016\/j.bioorg.2025.108596_bb0105","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.2174\/138161211798194459","article-title":"Prodrugs for targeted tumor therapies: recent developments in ADEPT, GDEPT and PMT","volume":"17","author":"Tietze","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bioorg.2025.108596_bb0110","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.addr.2017.09.003","article-title":"Cell-mediated enzyme prodrug cancer therapies","volume":"118","author":"Mooney","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"10","key":"10.1016\/j.bioorg.2025.108596_bb0115","doi-asserted-by":"crossref","first-page":"887","DOI":"10.2174\/138955710792007196","article-title":"Targeted enzyme prodrug therapies","volume":"10","author":"Schellmann","year":"2010","journal-title":"Mini-Rev. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108596_bb0120","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1016\/j.ymthe.2021.04.006","article-title":"Prodrugs and prodrug-activated systems in gene therapy","volume":"29","author":"Sheikh","year":"2021","journal-title":"Mol. Ther."},{"issue":"1\u20133","key":"10.1016\/j.bioorg.2025.108596_bb0125","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF02789482","article-title":"Human immune response to monoclonal antibody-enzyme conjugates in ADEPT pilot clinical trial","volume":"21","author":"Sharma","year":"1992","journal-title":"Cell Biophys."},{"issue":"12","key":"10.1016\/j.bioorg.2025.108596_bb0130","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1054\/bjoc.2001.1843","article-title":"Measurement of the critical DNA lesions produced by antibody-directed enzyme prodrug therapy (ADEPT) in vitro, in vivo and in clinical material","volume":"84","author":"Webley","year":"2001","journal-title":"Br. J. Cancer"},{"issue":"11","key":"10.1016\/j.bioorg.2025.108596_bb0135","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/nrc2247","article-title":"Carboxypeptidase-G2-based gene-directed enzyme-prodrug therapy: a new weapon in the GDEPT armoury","volume":"7","author":"Hedley","year":"2007","journal-title":"Nat. Rev. Cancer"},{"issue":"9","key":"10.1016\/j.bioorg.2025.108596_bb0140","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1200\/JCO.2004.10.005","article-title":"Virus-directed enzyme prodrug therapy: intratumoral administration of a replication-deficient adenovirus encoding nitroreductase to patients with resectable liver cancer","volume":"22","author":"Palmer","year":"2004","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108596_bb0145","doi-asserted-by":"crossref","first-page":"619","DOI":"10.18632\/oncotarget.27478","article-title":"In vitro studies on CNGRC-CPG2 fusion proteins for ligand-directed enzyme prodrug therapy for targeted cancer therapy","volume":"11","author":"Al-Mansoori","year":"2020","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.bioorg.2025.108596_bb0150","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/s41589-021-00932-1","article-title":"Engineering CAR-T cells to activate small-molecule drugs in situ","volume":"18","author":"Gardner","year":"2022","journal-title":"Nat. Chem. Biol."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108596_bb0155","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1432-1033.1985.tb08860.x","article-title":"Purification and properties of carboxypeptidase G2 from Pseudomonas sp. strain RS-16. Use of a novel triazine dye affinity method","volume":"148","author":"Sherwood","year":"1985","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bioorg.2025.108596_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115292","article-title":"Glucarpidase (carboxypeptidase G2): biotechnological production, clinical application as a methotrexate antidote, and placement in targeted cancer therapy","volume":"166","author":"Moradbeygi","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"20","key":"10.1016\/j.bioorg.2025.108596_bb0165","first-page":"4735","article-title":"Gene-directed enzyme prodrug therapy with a mustard prodrug\/carboxypeptidase G2 combination","volume":"56","author":"Marais","year":"1996","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108596_bb0170","doi-asserted-by":"crossref","first-page":"9191233","DOI":"10.1155\/2022\/9191233","article-title":"Ultrasonically enhanced ZD2767P-carboxypeptidase G2 deactivates cisplatin-resistant human lung Cancer cells","volume":"2022","author":"Liu","year":"2022","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"34","key":"10.1016\/j.bioorg.2025.108596_bb0175","doi-asserted-by":"crossref","first-page":"6295","DOI":"10.1021\/acs.orglett.3c02130","article-title":"Development of a p-Hydroxybenzyl-alcohol-linked glutamate prodrug for activation by Pseudomonas carboxypeptidase G2","volume":"25","author":"Lee","year":"2023","journal-title":"Org. Lett."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108596_bb0180","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1046\/j.0022-3042.2001.00715.x","article-title":"Substrate specificity, inhibition and enzymological analysis of recombinant human glutamate carboxypeptidase II","volume":"80","author":"Barinka","year":"2002","journal-title":"J. Neurochem."},{"issue":"21","key":"10.1016\/j.bioorg.2025.108596_bb0185","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1111\/bph.13576","article-title":"The therapeutic and diagnostic potential of the prostate specific membrane antigen\/glutamate carboxypeptidase II (PSMA\/GCPII) in cancer and neurological disease","volume":"173","author":"Evans","year":"2016","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108596_bb0190","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/07328318808068708","article-title":"Preparation of 8-chloropurine nucleosides through the reaction between their C-8 lithiated species and p-toluenesulfonyl chloride","volume":"7","author":"Hayakawa","year":"1988","journal-title":"Nucleosides Nucleotides"},{"key":"10.1016\/j.bioorg.2025.108596_bb0195","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.pep.2016.06.015","article-title":"Soluble expression, purification and functional characterisation of carboxypeptidase G2 and its individual domains","volume":"127","author":"Jeyaharan","year":"2016","journal-title":"Protein Expr. Purif."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108596_bb0200","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0003-2697(89)90602-7","article-title":"Calculation of protein extinction coefficients from amino acid sequence data","volume":"182","author":"Gill","year":"1989","journal-title":"Anal. Biochem."},{"issue":"23","key":"10.1016\/j.bioorg.2025.108596_bb0205","doi-asserted-by":"crossref","first-page":"7207","DOI":"10.1016\/S0021-9258(19)45873-0","article-title":"Purification and properties of carboxypeptidase G1","volume":"246","author":"McCullough","year":"1971","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108596_bb0210","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0167-4838(82)90296-5","article-title":"Metal ion-promoted binding of proteins to immobilized triazine dye affinity adsorbents","volume":"700","author":"Hughes","year":"1982","journal-title":"Biochim. Biophys. Acta"},{"issue":"22","key":"10.1016\/j.bioorg.2025.108596_bb0215","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202101176","article-title":"Patient-derived organoids can guide personalized-therapies for patients with advanced breast cancer","volume":"8","author":"Chen","year":"2021","journal-title":"Adv. Sci."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108596_bb0220","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.chembiol.2020.01.004","article-title":"Mechanism of Activation of AMPK by Cordycepin","volume":"27","author":"Hawley","year":"2020","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.bioorg.2025.108596_bb0225","article-title":"Cordycepin inhibits triple-negative breast Cancer cell migration and invasion by regulating EMT-TFs SLUG, TWIST1, SNAIL1, and ZEB1","volume":"12","author":"Wei","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bioorg.2025.108596_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2024.111178","article-title":"Cordycepin inhibits glioma growth by downregulating PD-L1 expression via the NOD-like receptor\/NFKB1\/STAT1 axis","volume":"400","author":"Chen","year":"2024","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bioorg.2025.108596_bb0235","article-title":"Development of ZD2767P-carboxypeptidase G2-ultrasound therapy against cisplatin-resistant cancer","volume":"13","author":"Yu","year":"2023","journal-title":"Front. Oncol."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108596_bb0240","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1021\/acsmedchemlett.4c00071","article-title":"Intracellular pharmacokinetics of activated drugs in a prodrug-enzyme-ultrasound system: evaluations on ZD2767P+CPG2+US","volume":"15","author":"Yu","year":"2024","journal-title":"ACS Med. Chem. Lett."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108596_bb0245","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1021\/acs.molpharmaceut.0c00008","article-title":"Ultrasound enhances ZD2767P-carboxypeptidase G2 against Chemoresistant ovarian Cancer cells by altering the intracellular pharmacokinetics of ZD2767D","volume":"17","author":"Liu","year":"2020","journal-title":"Mol. Pharm."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108596_bb0250","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1080\/17425247.2016.1232248","article-title":"Pharmacokinetic profiles of cancer sonochemotherapy","volume":"14","author":"Zhang","year":"2017","journal-title":"Expert Opin. Drug Deliv."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108596_bb0255","doi-asserted-by":"crossref","first-page":"485","DOI":"10.38212\/2224-6614.3464","article-title":"Cordycepin inhibits ERK pathway to suppress FGF9-induced tumorigenesis with MA-10 mouse Leydig tumor cells","volume":"31","author":"Chen","year":"2023","journal-title":"J. Food Drug Anal."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108596_bb0260","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.stem.2019.10.010","article-title":"Patient-derived organoids predict Chemoradiation responses of locally advanced rectal Cancer","volume":"26","author":"Yao","year":"2020","journal-title":"Cell Stem Cell"},{"issue":"6","key":"10.1016\/j.bioorg.2025.108596_bb0265","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41571-021-00470-8","article-title":"Unlocking the potential of antibody-drug conjugates for cancer therapy","volume":"18","author":"Drago","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108596_bb0270","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1021\/bc00019a001","article-title":"Generation of cytotoxic agents by targeted enzymes","volume":"4","author":"Senter","year":"1993","journal-title":"Bioconjug. Chem."},{"issue":"16","key":"10.1016\/j.bioorg.2025.108596_bb0275","doi-asserted-by":"crossref","first-page":"5321","DOI":"10.1021\/jm0502182","article-title":"Novel fluorinated prodrugs for activation by carboxypeptidase G2 showing good in vivo antitumor activity in gene-directed enzyme prodrug therapy","volume":"48","author":"Davies","year":"2005","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2025.108596_bb0280","first-page":"3119","article-title":"Pharmacokinetic analysis of two-step approaches using bifunctional and enzyme-conjugated antibodies","volume":"51","author":"Yuan","year":"1991","journal-title":"Cancer Res."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825004766?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825004766?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T14:05:40Z","timestamp":1748959540000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825004766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":56,"alternative-id":["S0045206825004766"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108596","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of an adenosine deaminase-resistant cordycepin prodrug activated by Pseudomonas carboxypeptidase G2","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108596","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108596"}}